The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
PNTG · Healthcare · Shallow moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
ADCT · Healthcare · Shallow moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
VXRT · Healthcare · Shallow moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
| Measure | PNTG | ADCT | CDRE | VXRT |
|---|---|---|---|---|
| Moat Score (0–100) | 55 (highest) | 55 (highest) | 55 (highest) | 54 |
| Methodology version | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 |
| Business trend | 95 (highest) | 42 | 55 | 67 |
| Pricing power | — | 100 (highest) | 68 | — |
| Returns on capital | 28 | — | 52 (highest) | 6 |
| Balance-sheet safety | 35 | 55 | 71 | 100 (highest) |
| Capital discipline | 60 (highest) | 24 | 28 | 44 |
| Price vs. high estimate | 492% above high estimate | No price data | 136% above high estimate (largest discount to high estimate) | No price data |
| Market cap | $1.4B | $158.4M | $1.2B | $120.2M |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filings as of | FY2025 | FY2025 | FY2025 | FY2025 |